Last Updated on June 22, 2023

Prostate Cancer- Impact Score, Ranking, SJR, h-index, Citescore, Rating, Publisher, ISSN, and Other Important Details


Published By: Hindawi Limited

Abbreviation: Prostate Cancer




Impact Score

The impact Score or journal impact score (JIS) is equivalent to Impact Factor. The impact factor (IF) or journal impact factor (JIF) of an academic journal is a scientometric index calculated by Clarivate that reflects the yearly mean number of citations of articles published in the last two years in a given journal, as indexed by Clarivate's Web of Science. On the other hand, Impact Score is based on Scopus data.

1.17

SJR

 0.364

h-Index

 14

Rank

 13362

Important Details

Title Prostate Cancer
Standard Abbreviation Prostate Cancer
Type of Publication Journal
Discipline Oncology (Q3); Urology (Q3); Cancer Research (Q4)
Impact Score 1.17
SCImago Journal Rank (SJR) 0.364
h-index 14
Overall Rank 13362
Publisher Name Hindawi Limited
Publication Country Egypt
International Standard Serial Number (ISSN) 20903111, 2090312X
Coverage and History 2011, 2013-2022
Best Quartile Q3
Total Citations Received
(Last 3 Year)
53

About Prostate Cancer


Prostate Cancer is a journal published by Hindawi Limited. This journal covers the area[s] related to Oncology, Urology, Cancer Research, etc. The coverage history of this journal is as follows: 2011, 2013-2022. The rank of this journal is 13362. This journal's impact score, h-index, and SJR are 1.17, 14, and 0.364, respectively. The ISSN of this journal is/are as follows: 20903111, 2090312X.

The best quartile of Prostate Cancer is Q3. This journal has received a total of 53 citations during the last three years (Preceding 2022).


Prostate Cancer Impact Score 2022-2023


The latest impact score (IS) of the Prostate Cancer is 1.17. It is computed in the year 2023 as per its definition and based on Scopus data. 1.17

It is decreased by a factor of around 0.6, and the percentage change is -33.9% compared to the preceding year 2021, indicating a falling trend.

The impact score (IS), also denoted as the Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.

Table Setting

Prediction of Prostate Cancer Impact Score 2023


Impact Score 2022 of Prostate Cancer is 1.17. If a similar downward trend continues, IS may decrease in 2023 as well.


Impact Score Graph


Check below the Impact Score trends of Prostate Cancer. This is based on Scopus data.


Year Impact Score (IS)
2023/2024 Coming Soon
2022 1.17
2021 1.77
2020 1.83
2019 3.20
2018 2.50
2017 2.68
2016 2.58
2015 0.25
2014 2.00

Prostate Cancer h-index


  Table Setting

The h-index of Prostate Cancer is 14. By definition of the h-index, this journal has at least 14 published articles with more than 14 citations.

What is h-index?

The h-index (also known as the Hirsch index or Hirsh index) is a scientometric parameter used to evaluate the scientific impact of the publications and journals. It is defined as the maximum value of h such that the given Journal has published at least h papers and each has at least h citations.




Prostate Cancer ISSN


The International Standard Serial Number (ISSN) of Prostate Cancer is/are as follows: 20903111, 2090312X.

The ISSN is a unique 8-digit identifier for a specific publication like Magazine or Journal. The ISSN is used in the postal system and in the publishing world to identify the articles that are published in journals, magazines, newsletters, etc. This is the number assigned to your article by the publisher, and it is the one you will use to reference your article within the library catalogues.

ISSN code (also called as "ISSN structure" or "ISSN syntax") can be expressed as follows: NNNN-NNNC
Here, N is in the set {0,1,2,3...,9}, a digit character, and C is in {0,1,2,3,...,9,X}

Table Setting

Prostate Cancer Ranking and SCImago Journal Rank (SJR)


The Prostate Cancer is ranked 13362 among 27955 Journals, Conferences, and Book Series. As per SJR, this journal is ranked 0.364.

SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.


Prostate Cancer Publisher


Table Setting

The publisher of Prostate Cancer is Hindawi Limited. The publishing house of this journal is located in the Egypt. Its coverage history is as follows: 2011, 2013-2022.


Call For Papers (CFPs)


Please check the official website of this journal to find out the complete details and Call For Papers (CFPs).


Abbreviation


The International Organization for Standardization 4 (ISO 4) abbreviation of Prostate Cancer is Prostate Cancer. ISO 4 is an international standard which defines a uniform and consistent system for the abbreviation of serial publication titles, which are published regularly. The primary use of ISO 4 is to abbreviate or shorten the names of scientific journals using the technique of List of Title Word Abbreviations (LTWA).

As ISO 4 is an international standard, the abbreviation ('Prostate Cancer') can be used for citing, indexing, abstraction, and referencing purposes.


How to publish in Prostate Cancer


If your area of research or discipline is related to Oncology, Urology, Cancer Research, etc., please check the journal's official website to understand the complete publication process.


Acceptance Rate


There are several factors that influence the acceptance rate of any academic journal. Here are some critical parameters that are considered while calculating the acceptance rate:

  • Interest/demand of researchers/scientists for publishing in a specific journal/conference.
  • The complexity of the peer review process and timeline.
  • Time taken from draft submission to final publication.
  • Number of submissions received and acceptance slots
  • And Many More.

The simplest way to find out the acceptance rate or rejection rate of a Journal/Conference is to check with the journal's/conference's editorial team through emails or through the official website.



Frequently Asked Questions (FAQ)


What is the impact score of Prostate Cancer?

The latest impact score of Prostate Cancer is 1.17. It is computed in the year 2023.


What is the h-index of Prostate Cancer?

The latest h-index of Prostate Cancer is 14. It is evaluated in the year 2023.


What is the SCImago Journal Rank (SJR) of Prostate Cancer?

The latest SCImago Journal Rank (SJR) of Prostate Cancer is 0.364. It is calculated in the year 2023.


What is the ranking of Prostate Cancer?

The latest ranking of Prostate Cancer is 13362. This ranking is among 27955 Journals, Conferences, and Book Series. It is computed in the year 2023.


Who is the publisher of Prostate Cancer?

Prostate Cancer is published by Hindawi Limited. The publication country of this journal is Egypt.


What is the abbreviation of Prostate Cancer?

This standard abbreviation of Prostate Cancer is Prostate Cancer.


Is "Prostate Cancer" a Journal, Conference or Book Series?

Prostate Cancer is a journal published by Hindawi Limited.


What is the scope of Prostate Cancer?

The scope of Prostate Cancer is as follows:

  • Oncology
  • Urology
  • Cancer Research

For detailed scope of Prostate Cancer, check the official website of this journal.


What is the ISSN of Prostate Cancer?

The International Standard Serial Number (ISSN) of Prostate Cancer is/are as follows: 20903111, 2090312X.


What is the best quartile for Prostate Cancer?

The best quartile for Prostate Cancer is Q3.


What is the coverage history of Prostate Cancer?

The coverage history of Prostate Cancer is as follows 2011, 2013-2022.


Credits and Sources


  • Scimago Journal & Country Rank (SJR), https://www.scimagojr.com/
  • Journal Impact Factor, https://clarivate.com/
  • Issn.org, https://www.issn.org/
  • Scopus, https://www.scopus.com/

Note: The impact score shown here is equivalent to the average number of times documents published in a journal/conference in the past two years have been cited in the current year (i.e., Cites / Doc. (2 years)). It is based on Scopus data and can be a little higher or different compared to the impact factor (IF) produced by Journal Citation Report. Please refer to the Web of Science data source to check the exact journal impact factor ™ (Thomson Reuters) metric.


Impact Score, SJR, h-Index, and Other Important metrics of These Journals, Conferences, and Book Series


Journal/Conference/Book Title Type Publisher Ranking SJR h-index Impact Score
Journal of Business Economics and Management Journal Vilnius Gediminas Technical University 10343 45 2.81
Zeitschrift fur Germanistische Linguistik Journal De Gruyter Mouton 22945 15 0.19
Marine Biology Research Journal Taylor and Francis Ltd. 13573 42 1.06
Journal of Education and Work Journal Brill Academic Publishers 9268 43 1.93
European Surgery - Acta Chirurgica Austriaca Journal Springer Medizin 16873 23 0.58
SPE International Formation Damage Control Symposium Proceedings Conference And Proceedings 21934 16 0.00
Proceedings of the ACM SIGKDD International Conference on Knowledge Discovery and Data Mining Conference And Proceedings 4334 192 0.00
Transactions on Embedded Computing Systems Journal Association for Computing Machinery (ACM) 6019 61 2.25
Brazilian Symposium of Computer Graphic and Image Processing Conference And Proceedings 16004 32 0.00
East African journal of public health Journal East African Public Health Association 19634 23 0.00

Check complete list




Prostate Cancer Impact Score (IS) Trend

Table: Impact Score

Year Impact Score (IS)
2023/2024 Updated Soon
2022 1.17
2021 1.77
2020 1.83
2019 3.20
2018 2.50
2017 2.68
2016 2.58
2015 0.25
2014 2.00



Top Journals/Conferences in Oncology

Ca-A Cancer Journal for Clinicians
Wiley-Blackwell | United States

Nature Reviews Cancer
Nature Publishing Group | United Kingdom

Nature Reviews Clinical Oncology
Nature Publishing Group | United Kingdom

Cancer Cell
Cell Press | United States

Lancet Oncology, The
Elsevier Ltd. | United Kingdom

Annals of Oncology
Elsevier Ltd. | United Kingdom

Journal of Clinical Oncology
Lippincott Williams and Wilkins Ltd. | United States

Nature Cancer
| United States

Molecular Cancer
BioMed Central Ltd. | United Kingdom

JAMA Oncology
American Medical Association | United States

Cancer Discovery
American Association for Cancer Research Inc. | United States

Lancet Regional Health - Europe, The
Elsevier Ltd. | United Kingdom

Journal of Hematology and Oncology
BioMed Central Ltd. | United Kingdom

Journal of Thoracic Oncology
International Association for the Study of Lung Cancer | United States

Journal of the National Cancer Institute
Oxford University Press | United Kingdom

See All

Top Journals/Conferences in Urology

Lancet Neurology, The
Elsevier Ltd. | United Kingdom

European Urology
Elsevier | Netherlands

JAMA Neurology
American Medical Association | United States

Nature Reviews Neurology
Nature Publishing Group | United Kingdom

Molecular Neurodegeneration
BioMed Central Ltd. | United Kingdom

Acta Neuropathologica
Springer Verlag | Germany

Neuro-Oncology
Oxford University Press | United Kingdom

Brain
Oxford University Press | United Kingdom

Annals of Neurology
John Wiley & Sons Inc. | United States

Alzheimer's and Dementia
John Wiley & Sons Inc. | United States

Journal of Neurology, Neurosurgery and Psychiatry
BMJ Publishing Group | United Kingdom

Autism in Adulthood
Mary Ann Liebert Inc. | United States

Sleep Medicine Reviews
Elsevier BV | United Kingdom

Ageing Research Reviews
Elsevier Ireland Ltd | Ireland

Stroke
American Heart Association | United States

See All

Top Journals/Conferences in Cancer Research

Nature Reviews Cancer
Nature Publishing Group | United Kingdom

Cancer Cell
Cell Press | United States

Cell Host and Microbe
Cell Press | United States

Journal of Clinical Oncology
Lippincott Williams and Wilkins Ltd. | United States

Nature Cancer
| United States

Molecular Cancer
BioMed Central Ltd. | United Kingdom

JAMA Oncology
American Medical Association | United States

Signal Transduction and Targeted Therapy
Springer Nature | United Kingdom

Journal of Hematology and Oncology
BioMed Central Ltd. | United Kingdom

Journal of the National Cancer Institute
Oxford University Press | United Kingdom

Neuro-Oncology
Oxford University Press | United Kingdom

Clinical Cancer Research
American Association for Cancer Research Inc. | United States

Annual Review of Cancer Biology
Annual Reviews Inc. | United States

Drug Resistance Updates
Churchill Livingstone | United States

Trends in Cancer
Cell Press | United States

See All